Anti-CTLA-8 / IL-17a Reference Antibody (secukinumab)
Reagent
Code: #139982
blur_circular Chemical Specifications
inventory_2
Storage & Handling
Storage
-20℃
description Product Description
Used in the treatment of autoimmune diseases such as plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis. It works by neutralizing interleukin-17A, a key cytokine involved in inflammatory pathways, thereby reducing inflammation and disease symptoms. Commonly administered via subcutaneous injection, it helps improve skin clearance, joint function, and quality of life in affected patients.
shopping_cart Available Sizes & Pricing
Cart
No products
Subtotal:
0.00
Total
0.00
THB